Agnes Jager Selected Research

Agnes Jager Research Topics

Disease

109	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2009
61	Neoplasms (Cancer) 03/2024 - 08/2009
9	Neoplasm Metastasis (Metastasis) 01/2024 - 10/2013
6	Circulating Neoplastic Cells 01/2024 - 02/2016
6	Triple Negative Breast Neoplasms 09/2023 - 02/2013
4	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 08/2012
3	Disease Progression 11/2023 - 02/2016
3	Cardiotoxicity 01/2022 - 08/2020
2	COVID-19 01/2024 - 12/2023
2	Neutropenia 01/2020 - 04/2015
2	Pain (Aches) 09/2016 - 08/2012
2	Inflammation (Inflammations) 12/2012 - 04/2002
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2024
1	Venous Thromboembolism 12/2023
1	Thrombophilia 12/2023
1	Carcinoma (Carcinomatosis) 11/2023
1	Lobular Carcinoma 11/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2023
1	Residual Neoplasm 01/2023
1	Melanoma (Melanoma, Malignant) 03/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Fatty Liver 01/2022
1	Dyspepsia (Indigestion) 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Alopecia (Baldness) 08/2021
1	Heart Failure 01/2021
1	Aneuploidy (Aneuploid) 01/2021

Drug/Important Bio-Agent (IBA)

21	Estrogen ReceptorsIBA 03/2024 - 10/2010
15	Tamoxifen FDA LinkGeneric 03/2024 - 06/2013
15	Hormones (Hormone)IBA 01/2024 - 10/2010
11	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 12/2018
11	Biomarkers (Surrogate Marker)IBA 07/2023 - 03/2015
10	4-hydroxy-N-desmethyltamoxifenIBA 12/2023 - 03/2015
8	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2024 - 09/2014
8	Cell-Free Nucleic AcidsIBA 01/2023 - 01/2017
7	Paclitaxel (Taxol)FDA LinkGeneric 11/2023 - 10/2016
7	AnthracyclinesIBA 09/2023 - 08/2009
6	Trastuzumab (Herceptin)FDA Link 01/2024 - 10/2016
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 09/2014
6	human ERBB2 proteinIBA 01/2024 - 10/2016
5	Carboplatin (JM8)FDA LinkGeneric 09/2023 - 09/2019
5	Progesterone Receptors (Progesterone Receptor)IBA 05/2021 - 02/2011
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022 - 09/2014
3	taxaneIBA 01/2024 - 02/2012
3	RNA (Ribonucleic Acid)IBA 11/2023 - 02/2016
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2023 - 04/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2023 - 02/2016
3	abemaciclibIBA 02/2023 - 02/2021
3	Circulating Tumor DNAIBA 01/2023 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2022 - 02/2016
3	MicroRNAs (MicroRNA)IBA 12/2021 - 01/2014
3	Aromatase InhibitorsIBA 01/2020 - 02/2016
3	Phenobarbital (Luminal)FDA Link 01/2020 - 08/2011
2	palbociclibIBA 02/2023 - 02/2021
2	ribociclibIBA 02/2023 - 02/2021
2	IodineIBA 11/2022 - 01/2017
2	Estradiol (Delestrogen)FDA LinkGeneric 11/2022 - 11/2020
2	Diphosphonates (Bisphosphonates)IBA 01/2022 - 09/2016
2	Estrogens (Estrogen)FDA Link 01/2022 - 05/2021
2	TeaIBA 02/2021 - 11/2020
2	Capsules (Microcapsules)IBA 01/2020 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2020
2	olaparibIBA 01/2020 - 01/2020
2	Bevacizumab (Avastin)FDA Link 10/2016 - 04/2016
2	Antidepressive Agents (Antidepressants)IBA 02/2016 - 06/2013
2	Fluoxetine (Prozac)FDA LinkGeneric 02/2016 - 06/2013
2	Paroxetine (Paxil)FDA LinkGeneric 02/2016 - 06/2013
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2024
1	PlatinumIBA 02/2024
1	Immune Checkpoint InhibitorsIBA 09/2023
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 09/2023
1	Capecitabine (Xeloda)FDA Link 09/2023
1	N,N- dimethyl- N- hexadecyl- 1- octadecylammonium (DDAC)IBA 09/2023
1	Mitogen-Activated Protein KinasesIBA 09/2023
1	Cyclin-Dependent Kinase 4IBA 02/2023
1	16-fluoroestradiolIBA 11/2022
1	Cytostatic AgentsIBA 02/2022
1	Probenecid (Benemid)FDA LinkGeneric 01/2022
1	Ibandronic Acid (Boniva)FDA Link 01/2022
1	LipidsIBA 01/2022
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2022
1	Progestins (Progestagens)IBA 05/2021
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2021
1	Oral ContraceptivesIBA 01/2021
1	ElementsIBA 01/2021

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 02/2024 - 08/2009
31	Therapeutics 01/2024 - 02/2012
10	Adjuvant Chemotherapy 11/2023 - 10/2009
8	Radiotherapy 01/2024 - 02/2015
5	Neoadjuvant Therapy 01/2024 - 01/2017
5	Segmental Mastectomy (Lumpectomy) 01/2020 - 02/2015
4	Mastectomy (Mammectomy) 12/2019 - 02/2015
2	Aftercare (After-Treatment) 02/2023 - 01/2018
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 05/2021 - 08/2020
2	Adjuvant Radiotherapy 11/2015 - 02/2015
1	Electronic Nose 03/2024
1	Immunotherapy 01/2024
1	Continuity of Patient Care 01/2024
1	Terminal Care (Care, Terminal) 12/2023
1	Lymph Node Excision (Lymph Node Dissection) 11/2022